Blog
PPC Q2 Earnings Miss Estimates on Commodity Pricing Pressure
Pilgrim’s Pride Corporation PPC reported second-quarter 2026 results, wherein both the top and bottom lines decreased year over year. Both metrics fell short of the Zacks Consensus Estimate.
Mid-America Apartment Q2 FFO Misses Estimates as Same-Store NOI Falls
Mid-America Apartment Communities, Inc. MAA reported second-quarter 2026 core funds from operations (FFO) per share of $2.08, missing the Zacks Consensus Estimate of $2.10. The metric declined 3.3%
Natural Foods Stocks Gain as Consumers Prioritize Health & Wellness
An updated edition of the June 12, 2026 article.Natural food products have become a mainstream part of consumer spending as health, nutrition and sustainability increasingly influence purchasing
Is ISRG Winning the Next Phase of Robotic Surgery Beyond Urology?
Intuitive Surgical ISRG is steadily expanding its robotic-assisted surgery beyond its traditional strength in urology, with general surgery and emerging specialties becoming increasingly important
Revvity to Report Q2 Earnings: What's in Store for the Stock?
Revvity, Inc. RVTY is slated to report second-quarter 2026 results on Aug. 4, before market open.
In the last reported quarter, the company delivered an earnings surprise of 3.92%. RVTY’s earnings
EME Q2 Earnings Beat Estimates on Broad-Based Growth, Stock Up
EMCOR Group, Inc. EME reported solid second-quarter 2026 results, with earnings and revenues surpassing the Zacks Consensus Estimate. The company’s quarterly performance was driven by broad-based
BMY Q2 Earnings Beat Estimates, '26 View Raised, Stock Up
Bristol-Myers Squibb Company BMY reported second-quarter 2026 adjusted earnings per share (EPS) of $2.04, which comfortably beat the Zacks Consensus Estimate of $1.59. The reported EPS was up 40%
Sprouts Farmers Q2 Earnings Beat Despite Soft Comparable-Store Sales
Sprouts Farmers Market, Inc. SFM reported second-quarter 2026 results, wherein the top line marginally missed the Zacks Consensus Estimate, while the bottom line beat the mark. The company continued
Trouble Intensifies for AI-Fueled Tech Rally: Inverse ETFs to Benefit
Investor sentiment toward companies tied to the AI trade has weakened considerably in recent weeks, prolonging the sector's selloff and dimming its near-term prospects.
Beyond concerns over
PWR Q2 Earnings Beat on Electric Strength, 2026 View Raised, Stock Up
Quanta Services, Inc. PWR reported better-than-expected second-quarter 2026 results, with adjusted earnings and revenues beating the Zacks Consensus Estimate. Quanta’s performance benefited from
Duke Energy to Release Q2 Earnings: What's in Store for the Stock?
Duke Energy DUK is scheduled to release second-quarter 2026 results on Aug. 4, before market open. The company delivered an earnings surprise of 7.8% in the last reported quarter. Let’s discuss the
Vertiv Q2 Earnings Beat Estimates, Net Sales Rise Year over Year
Vertiv Holdings VRT delivered second-quarter 2026 adjusted earnings of $1.52 per share, up 60% year over year. The results beat the Zacks Consensus Estimate by 6.29%, supported by higher sales
Vanguard Treasury Bill ETF (VBIL) Touches Fresh 52-Week High
For investors seeking momentum, Vanguard 0-3 Month Treasury Bill ETF VBIL is probably on the radar now. The fund just hit a 52-week high and is up 0.5% from its 52-week low price of $75.31 per
VKTX Q2 Earnings Beat Estimates Despite Surge in R&D Costs
Viking Therapeutics VKTX reported a second-quarter 2026 loss of $1.10 per share, narrower than the Zacks Consensus Estimate of a loss of $1.21. The reported loss, however, widened from a loss of 58
ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise
Align Technology, Inc. ALGN reported second-quarter 2026 non-GAAP earnings of $2.64 per share, up 6.0% year over year. The figure beat the Zacks Consensus Estimate by 3.1%. Revenues increased 4.3%
NOV Q2 Earnings Surpass Estimates, Revenues Decrease Y/Y
NOV Inc. NOV reported second-quarter 2026 adjusted earnings of 31 cents per share, which beat the Zacks Consensus Estimate of 16 cents. The bottom line also increased 6.9% from the year-ago
Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026
Quest Diagnostics Incorporated DGX is combining broad testing demand, wider payer access, advanced diagnostics and partnership-led expansion to support revenue growth in 2026.
For investors, the key
Teladoc Health Q2 Earnings Beat Estimates on Integrated Care Strength
Teladoc Health, Inc. TDOC reported a second-quarter 2026 adjusted loss of 21 cents per share, which beat the Zacks Consensus Estimate of a loss of 24 cents. However, the bottom line deteriorated
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised
Bausch Health Companies Inc. BHC reported second-quarter 2026 adjusted earnings of $1.26 per share, up 40% year over year. The figure beat the Zacks Consensus Estimate of 96 cents.
Revenues
Fair Isaac Q3 Earnings Beat Estimates on Scores, Revenues Up Y/Y
Fair Isaac Corporation FICO reported third-quarter fiscal 2026 non-GAAP earnings of $12.18 per share, up 42.1% year over year and 1.33% above the Zacks Consensus Estimate. Revenues rose 25.7% to
TT's Q2 Earnings & Revenues Beat Estimates, Increase Year Over Year
Trane Technologies plc TT reported impressive second-quarter 2026 results, with both earnings and revenues beating the Zacks Consensus Estimate.
TT’s adjusted earnings of $4.31 per share topped the
TER Rides on Strong Semiconductor Test Segment: More Upside Ahead?
Teradyne TER is benefiting from a powerful surge in its semiconductor test segment, fueled by the global build-out of AI data centers and the resulting demand for advanced compute and memory





